{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T10:05:42Z","timestamp":1784023542173,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd006005","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2010,7,7]],"date-time":"2010-07-07T00:00:00Z","timestamp":1278460800000}}],"reference-count":74,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006005.pub2","type":"journal-article","created":{"date-parts":[[2010,6,29]],"date-time":"2010-06-29T20:41:58Z","timestamp":1277844118000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation"],"prefix":"10.1002","volume":"2010","author":[{"given":"Lior H","family":"Katz","sequence":"first","affiliation":[{"name":"Sheba Medical Center; Gastroenterology Department; Tel-Hashomer Ramat-Gan Israel 52621"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Tur-Kaspa","sequence":"additional","affiliation":[{"name":"Rabin Medical Center - Beilison Campus; Department of Internal Medicine D; Beilinson Campus Petah Tigva Israel 49100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G","family":"Guy","sequence":"additional","affiliation":[{"name":"Sackler School of Medicine; Tel Aviv University Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mical","family":"Paul","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine; Infectious Diseases Unit; Tel Aviv University Tel Aviv Israel 49100"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,7,7]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD006005.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/hep.22524","article-title":"A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis","volume":"48","author":"Angus","year":"2008","journal-title":"Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD006005.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0168-8278(03)00087-4","article-title":"A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation","volume":"38","author":"Buti","year":"2003","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD006005.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0168-8278(01)00039-3","article-title":"Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation","volume":"34","author":"Naoumov","year":"2001","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD006005.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0041-1345(02)02637-4","article-title":"Is lamivudine with 1-week HBlg as effective as long-term high-dose HBlg in HBV prophylaxis after liver transplantation?","volume":"34","author":"Park","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD006005.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/01.tp.0000277289.23677.0a","article-title":"Adherence to lamivudine after an early withdrawal of hepatitis B immune globulin plays an important role in the long-term prevention of hepatitis B virus recurrence","volume":"84","author":"Buti","year":"2007","journal-title":"Transplantation"},{"issue":"1-2","key":"10.1002\/14651858.CD006005.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0041-1345(98)01720-5","article-title":"Developing strategies for prevention and treatment of recurrent HBV in liver transplantation","volume":"31","author":"Nery","year":"1999","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0007|cit7","unstructured":"NCT00059267 Prevention of recurrent hepatitis B after liver transplantation http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00059267"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0008|cit8","unstructured":"NCT01046799 Prevention of hepatitis B virus reinfection after liver transplantation with entecavir http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01046799"},{"issue":"4","key":"10.1002\/14651858.CD006005.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1399-0012.2007.00678.x","article-title":"Intramuscular hepatitis B immunoglobulin (HBIG) and nucleosides for prevention of recurrent hepatitis B following liver transplantation: comparison with other HBIG regimens","volume":"21","author":"Anderson","year":"2007","journal-title":"Clinical Transplantation"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0010|cit10","first-page":"238A","article-title":"A randomized study to assess the safety and efficacy of adefovir dipivoxil substitution for hepatitis B immune globulin in liver transplantation patients receiving long-term low dose IM HBIg and lamivudine prophylaxis","volume":"46","author":"Angus","year":"2007","journal-title":"Hepatology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD006005.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1002\/lt.21614","article-title":"Liver transplantation for hepatitis B: what is the best hepatitis B immune globulin\/antiviral regimen?","volume":"14","author":"Angus","year":"2008","journal-title":"Liver Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD006005.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00000658-200205000-00002","article-title":"New era of liver transplantation for hepatitis B: a 17-year single-center experience","volume":"235","author":"Anselmo","year":"2002","journal-title":"Annals of Surgery"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00007890-199702150-00011","article-title":"Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation","volume":"63","author":"Ben-Ari","year":"1997","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0041-1345(03)00008-3","article-title":"Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipients","volume":"35","author":"Ben-Ari","year":"2003","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0015|cit15","first-page":"217A","article-title":"Randomized clinical trial of lamivudine vs lamivudine + hepatitis B gammaglobulin in the prevention of HBV recurrence after liver transplantation - preliminary results","volume":"32","author":"Buti","year":"2000","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD006005.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods for combining randomized clinical trials: strengths and limitations","volume":"6","author":"DeMets","year":"1987","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/gast.2003.50013","article-title":"Histological outcome during long-term lamivudine therapy","volume":"124","author":"Dienstag","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1034\/j.1600-6143.2003.00191.x","article-title":"Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: long-term results","volume":"3","author":"Dumortier","year":"2003","journal-title":"American Journal of Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD006005.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2008.10.001","article-title":"EASL Clinical Practice Guidelines: management of chronic hepatitis B","volume":"50","author":"European Association For The Study Of The Liver","year":"2009","journal-title":"Journal of Hepatology"},{"issue":"7109","key":"10.1002\/14651858.CD006005.pub2-BIB0020|cit20","first-page":"629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0021|cit21","unstructured":"Gluud C Nikolova D Klingenberg SL Alexakis N Als-Nielsen B Colli A Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2010, Issue 5. Art. No.: LIVER"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0140-6736(96)04444-3","article-title":"Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis","volume":"348","author":"Grellier","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa021812","article-title":"Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B","volume":"348","author":"Hadziyannis","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1053\/jlts.2000.18702","article-title":"An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy","volume":"6","author":"Han","year":"2000","journal-title":"Liver Transplantation"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0026|cit26","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009] The Cochrane Colloboration, 2009. Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1034\/j.1399-3062.2002.01012.x","article-title":"Evolving experience of hepatitis B virus prophylaxis in liver transplantation","volume":"4","author":"Honaker","year":"2002","journal-title":"Transplantation Infectious Diseases"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0028|cit28","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice1997 CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00003495-199958010-00015","article-title":"Lamivudine. A review of its therapeutic potential in chronic hepatitis B","volume":"58","author":"Jarvis","year":"1999","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.transproceed.2007.03.062","article-title":"Prophylaxis of recurrent hepatitis B in Chinese patients after liver transplantation using lamivudine combined with hepatitis B immune globulin according to the titer of antibody to hepatitis B surface antigen","volume":"39","author":"Jiao","year":"2007","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0031|cit31","doi-asserted-by":"crossref","unstructured":"Katz LH Paul M Guy DG Tur-Kaspa R Prevention of recurrent hepatitis B virus infection after liver transplantation: HBIg, antiviral drugs, or both? Systematic review and meta-analysis Transplantation Infectious Diseases 2010 [Epub ahead of print]","DOI":"10.1111\/j.1399-3062.2009.00470.x"},{"issue":"11","key":"10.1002\/14651858.CD006005.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodological quality and discrepancies between small and large randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJM199807093390201","article-title":"A one-year trial of lamivudine for chronic hepatitis B","volume":"339","author":"Lai","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1016\/S0041-1345(01)02567-2","article-title":"Comparison of the efficacy in prevention of hepatitis B virus recurrence after liver transplantation between HBIG and lamivudine","volume":"33","author":"Lee","year":"2001","journal-title":"Transplantation Proceedings"},{"issue":"2","key":"10.1002\/14651858.CD006005.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","article-title":"Chronic hepatitis B","volume":"45","author":"Lok","year":"2007","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.cgh.2008.02.055","article-title":"Hepatitis B immunoglobulin and lamivudine improve hepatitis B-related outcomes after liver transplantation: meta-analysis","volume":"6","author":"Loomba","year":"2008","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa020681","article-title":"Adefovir Dipivoxil 437 Study Group. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B","volume":"348","author":"Marcellin","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/hep.510280241","article-title":"Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin","volume":"28","author":"Markowitz","year":"1998","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/lt.500050601","article-title":"Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulin","volume":"5","author":"McCaughan","year":"1999","journal-title":"Liver Transplantation Surgery"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/00007890-200009150-00018","article-title":"Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: long-term follow-up","volume":"70","author":"Mutimer","year":"2000","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0042|cit42","first-page":"51","article-title":"Randomised trial of lamivudine (LAM) versus hepatitis B immunoglobulin (HBIG) for prophylaxis of HBV recurrence after liver transplantation","volume":"30","author":"Naoumov","year":"1999","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0168-8278(01)00039-3","article-title":"Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation","volume":"34","author":"Naoumov","year":"2001","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/lt.20277","article-title":"Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade","volume":"10","author":"Neff","year":"2004","journal-title":"Liver Transplantation"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0041-1345(02)02637-4","article-title":"Is lamivudine with 1-week HBlg as effective as long-term high-dose HBlg in HBV prophylaxis after liver transplantation?","volume":"34","author":"Park","year":"2002","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/hep.510290507","article-title":"Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group","volume":"29","author":"Perrillo","year":"1999","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/jhep.2001.21554","article-title":"A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B","volume":"33","author":"Perrillo","year":"2001","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/0003-4819-126-10-199705150-00012","article-title":"Liver transplantation and hepatitis B","volume":"126","author":"Poterucha","year":"1997","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1432-2277.2008.00784.x","article-title":"Lamivudine or lamivudine combined with hepatitis B immunoglobulin in prophylaxis of hepatitis B recurrence after liver transplantation: a meta-analysis","volume":"22","author":"Rao","year":"2009","journal-title":"Transplantation International"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0168-8278(94)80115-0","article-title":"Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP)","volume":"2","author":"Realdi","year":"1994","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0051|cit51","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1345\/aph.1D362","article-title":"Adefovir dipivoxil in the treatment of chronic hepatitis B","volume":"38","author":"Rivkin","year":"2004","journal-title":"Annals of Pharmacotherapy"},{"issue":"4","key":"10.1002\/14651858.CD006005.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJM199312163292503","article-title":"Liver transplantation in European patients with the hepatitis B surface antigen","volume":"329","author":"Samuel","year":"1993","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006005.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-2004-828679","article-title":"Management of hepatitis B in liver transplantation patients","volume":"24","author":"Samuel","year":"2004","journal-title":"Seminars in Liver Diseases"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0056|cit56","first-page":"1419","article-title":"Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients","volume":"38","author":"Schiff","year":"2003","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/lt.20981","article-title":"Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results","volume":"13","author":"Schiff","year":"2007","journal-title":"Liver Transplantation"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-0711-5-8","article-title":"Prevention and treatment of recurrent hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues","volume":"5","author":"Schreibman","year":"2006","journal-title":"Annals of Clinical Microbiology and Antimicrobials"},{"issue":"5","key":"10.1002\/14651858.CD006005.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/jlts.2001.28442","article-title":"Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation","volume":"7","author":"Seehofer","year":"2001","journal-title":"Liver Transplantation"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0041-1345(03)00065-4","article-title":"Comparison between levels of anti-HBS with a fixed administration dose of HBIG and a combination of HBIG and lamivudine for the prophylaxis of hepatitis B after liver transplantation","volume":"35","author":"Sousa","year":"2003","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/gut.40.5.568","article-title":"Hepatitis B virus infection and liver transplantation","volume":"40","author":"Terrault","year":"1997","journal-title":"Gut"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.510280237","article-title":"Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin","volume":"28","author":"Terrault","year":"1998","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0064|cit64","first-page":"389","article-title":"Hepatitis B virus and liver transplantation","volume-title":"Clinics in Liver Disease","volume":"3","author":"Terrault","year":"1999"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/hep.1840130402","article-title":"Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease","volume":"13","author":"Todo","year":"1991","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0168-8278(03)00396-9","article-title":"Prophylaxis with anti-HBs immune globulins and nucleoside analogues after liver transplantation for HBV infection","volume":"39","author":"Villamil","year":"2003","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.transproceed.2004.07.070","article-title":"Prevention of hepatitis B virus reinfection after orthotopic liver transplantation","volume":"36","author":"Wang","year":"2004","journal-title":"Transplantation Proceedings"},{"issue":"7644","key":"10.1002\/14651858.CD006005.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"3","key":"10.1002\/14651858.CD006005.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/lt.21043","article-title":"Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation","volume":"13","author":"Yi","year":"2007","journal-title":"Liver Transplantation"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1478-3231.2007.01611.x","article-title":"Prophylaxsis against recurrence of hepatitis B virus after liver transplantation: a retrospective analysis spanning 20 years","volume":"28","author":"Yilmaz","year":"2008","journal-title":"Liver International"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1399-0012.2006.00557.x","article-title":"Lamivudine monoprophylaxis for liver transplant recipients with non-replicating hepatitis B virus infection","volume":"21","author":"Yoshida","year":"2007","journal-title":"Clinical Transplantation"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S1089-3261(03)00044-8","article-title":"Nucleoside analogues and other antivirals for treatment of hepatitis B in the peritransplant period","volume":"7","author":"Yu","year":"2003","journal-title":"Clinical Liver Disease"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/lt.20701","article-title":"Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B immunoglobulin prophylaxis","volume":"12","author":"Zheng","year":"2006","journal-title":"Liver Transplantation"},{"key":"10.1002\/14651858.CD006005.pub2-BIB0074|cit74","first-page":"500","article-title":"Prevention and treatment of hepatitis B recurrence after liver transplantation","volume":"2","author":"Zhu","year":"2003","journal-title":"Hepatobiliary and Pancreatic Disorders International"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD006005.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T09:16:45Z","timestamp":1784020605000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006005.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,7,7]]},"references-count":74,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2010,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006005.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,7]]}}}